Qiu Rao

机构：Nanjing University of Chinese Medicine, Nanjing General Hospital of Nanjing Military Command, Sichuan Cancer Hospital, Hunan Xiangdian Test Research Institute (China), Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing University · ORCID：0000-0002-2674-1937

发表论文 146 篇 · 总被引 2924 次 · h-index 30

代表论文

• Recurrent Tuberous Sclerosis Complex/Mammalian Target of Rapamycin Mutations Define Primary Renal Hemangioblastoma as a Unique Entity Distinct From Its Central Nervous System Counterpart (2024 · The American Journal of Surgical Pathology · 被引 17)
• Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy (2023 · European Urology Oncology · 被引 17)
• GPNMB Expression Identifies FLCN-Associated Eosinophilic Renal Tumors With Heterogeneous Clinicopathologic Spectrum and Gene Expression Profiles (2025 · The American Journal of Surgical Pathology · 被引 13)
• SMARCA4/BRG1 deficiency induces a targetable dependence on oxidative phosphorylation in clear cell renal cell carcinoma (2025 · Carcinogenesis · 被引 11)
• Loss of YAP1 C‐terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement (2023 · Histopathology · 被引 11)
• Clinicopathologic and Molecular Characterization of Xanthomatous Giant Cell Renal Cell Carcinomas (2024 · The American Journal of Surgical Pathology · 被引 10)